CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- 4 Grant or award Chief Financial Officer acquired 390,614 shares (grant or award)
- 4 Grant or award Director acquired 15,625 shares (grant or award)
- 4 Grant or award Director acquired 181 shares (grant or award)
- 4 Grant or award Director acquired 181 shares (grant or award)
- 4 Grant or award Director acquired 181 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 30,095 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,048 shares (grant or award)
- 4 Grant or award Director acquired 181 shares (grant or award)
- 4 Open-market sale Director sold 27,771 shares at $0.52 ($14,438)
- 4 Open-market sale Director sold 1,845 shares at $0.65 ($1,199)
- 4 Open-market sale Director sold 10,957 shares at $0.66 ($7,243)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,429 shares at $0.69 ($986)
- 4 Open-market sale Director sold 25,500 shares at an average $0.74 ($18,895)
- 4 Open-market buy Director bought 51,500 shares at $1.16 ($59,740)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 4 · 70 filings